Ocugen Announces Initiation of Rolling Submission to Health Canada for COVAXIN
Ocugen, Inc. a biopharmaceutical company focused on discovering, developing and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from…
Read More...
Read More...
